Hypoxia‐related lncRNAs to build prognostic classifier and reveal the immune characteristics of EGFR wild type and low expression of PD‐L1 squamous and adenocarcinoma NSCLC

BACKGROUND: Recently, the development and application of targeted therapies like tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) have achieved remarkable survival benefits in non‐small cell lung cancer (NSCLC) treatment. However, epidermal growth factor receptor (EGFR) wild...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Fang, Wang, Min, Zhu, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Bioinformatics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419766/
https://www.ncbi.nlm.nih.gov/pubmed/34250747
http://dx.doi.org/10.1002/cam4.4126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419766/
https://www.ncbi.nlm.nih.gov/pubmed/34250747
http://dx.doi.org/10.1002/cam4.4126

Ejemplares similares